Replies to post #4278 on MediPharm Labs Corp (MEDIF)

[FUNMAN]

I thought NEPT's ER was terrible. The Street's knee jerk reaction agrees with me.

Look at their Cannabis revenues:

Revenues: 9.2M (+41.5%); Nutraceutical: 6.3M (-3.1%); Cannabis: 2.8M.

That doesn't show booming support for extraction. Moreover, that's a combination of Canada and U.S.

I am glad I sold my NEPT and moved it into MediPharm and Valens.

Day's High
2.01
Day's Low
1.93

Price
$2.00
Day's Change
-0.12 (-5.66%)

Volume(Heavy Day)
396,692
February 13, 2020 9:46am ET